Clinical Trial Update: Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting safety and preliminary efficacy data for the Percutaneous Transvenous Mitral Annuloplasty Device intended to reduce mitral regurg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Regurgitation

Drugs mentioned

• Percutaneous Transvenous Mitral Annuloplasty Device

Snippet

Sponsor: Viacor | Conditions: Heart Failure, Mitral Regurgitation | Phase 1 | Status: COMPLETED